Congress reconvenes in September for its last push to legislate before the...
Congress reconvenes in September for its last push to legislate before the November elections Congress is entering a very busy work period in September, the last before the November elections. GLI is...
View ArticleAs Deadly Liver Cancer Rises, Collaborative, Targeted Prevention and...
As Deadly Liver Cancer Rises, Collaborative, Targeted Prevention and Surveillance Necessary Global Liver Institute’s #OctoberIs4Livers Campaign Sheds Light on Unique Challenges and Solutions in...
View Article2025 ICD-10 Coding will include code for cholestatic pruritus – Pediatric &...
New changes in 2025 ICD-10 Coding includes a code for cholestatic pruritus Critical Path Global Impact Conference highlights collaborative progress The Critical Path Global Impact Conference...
View ArticleEmerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver...
Emerging Evidence in Liver Health: GLP-1, Pollution, and More Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies. Recent studies show promising...
View ArticleCancer Care for the Underrepresented #Octoberis4Livers – Liver Cancer News
Cancer Care for the Underrepresented #Octoberis4Livers Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and...
View ArticleCongress goes into recess in October while staff prepare for a potentially...
Congress goes into recess in October while staff work behind the scenes to prepare for a potentially busy November lame-duck session Congress is in recess with Representatives and Senators back in...
View ArticleWhy Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver...
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver Health Hepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a...
View ArticleTerri’s Story
Terri’s Story When my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the...
View ArticleScreening for MASLD is Cost-Effective for Patients – Fatty Liver Disease News
Screening for MASLD is Cost-Effective for Patients Emerging research continues to shape our understanding of liver health, from cost-effective screening for high-risk MASLD patients to alarming rates...
View ArticleInnovation Sparks New Ideas at NORD’s Breakthrough Summit – Pediatric & Rare...
Innovation Sparks New Ideas at NORD’s Breakthrough Summit Collaborative Voices across Rare Disorders Represented during the FDA Innovation Hub Global Liver Institute’s (GLI) Program Director of...
View Article